Pure Global

Respiratory syncytial Virus IgM ELISA - India CDSCO Medical Device Registration

Respiratory syncytial Virus IgM ELISA is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000101_d8edd776343a6ea2afa808787c13bc55_3a0fb8bb04a18d7a8dd1d7f10b2d14b9. This device is marketed under the brand name NovaLisa. The license holder is Dia Sure Immunodiagnostic LLP, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Respiratory syncytial Virus IgM ELISA
UID: IMP/IVD/2021/000101_d8edd776343a6ea2afa808787c13bc55_3a0fb8bb04a18d7a8dd1d7f10b2d14b9

Brand Name

NovaLisa

Device Class

Class B

Approving Authority

CDSCO

Product Information

The Respiratory syncytial Virus IgM ELISA is intended for the qualitative determination of IgM class antibodies against Respiratory syncytial Virus in human serum or plasma

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing